Exits
KKR’s ATU receives $25m and nears debt restructuring
KKR’s problem child Auto-Teile Unger (ATU) has entered an agreement with creditors in order to reduce its debt and receive a $25m liquidity injection.
Wonga buys VC-backed Billpay
Cash lender business Wonga, backed by a consortium of venture capital firms, has acquired online payment business Billpay, a portfolio company of numerous German VCs.
GCP rebrands to Kester and offloads TEG
The former European private equity division of Greenhill & Co, GCP Capital Partners, has simultaneously rebranded as Kester Capital and divested Travel Entertainment Group (TEG).
PE-backed TDF attracts €3.5-3.6bn offers
The private equity backers of broadcast tower operator Télédiffusion de France (TDF) are considering bids in the region of €3.5bn for the sale of the firm’s French unit, Reuters has reported.
SBOs account for 90% of €500m+ dealflow in Q3
The latest quarterly figures from unquote" data show that while the wave of secondary buyouts seems to have hit its apex in overall volume terms, such deals are still disproportionally prominent in the large-cap space.
Permira reaps £111m in Hugo Boss recap
Permira has recapitalised German luxury fashion retailer Hugo Boss, returning around 47% of the original investment to LPs.
Stock Spirits valued at £470m in IPO
Stock Spirits, a CEE-focused spirits producer backed by Oaktree Capital Management, started trading on the London Stock Exchange at 235p per share, valuing the business at £470m.
Providence picks up Exponent’s Ambassador
Providence Equity Partners has emerged as the successful bidder for Exponent Private Equity’s Ambassador Theatre Group (ATG).
BWK sells 20% Bizerba stake in owner buy-back
BWK Unternehmensbeteiligungsgesellschaft has sold its minority stake in food-processing equipment manufacturer Bizerba back to the firm's founders.
PE-backed Infinis and Merlin to float
Merlin Entertainments, backed by Blackstone Group and CVC Capital Partners, and Terra Firma’s Infinis Energy have both announced plans to float on the London Stock Exchange.
Advent secures Nocibé deal
Advent International and the Kreke family, which together own German retail group Douglas Holding, have entered exclusive talks to buy French perfume chain Nocibé from Charterhouse.
Equistone buys Européenne des Desserts in SBO
Equistone Partners has acquired French desserts maker Européenne des Desserts from Azulis Capital and Céréa Partenaire.
Hutton Collins buys Byron
Hutton Collins Partners has acquired high-end burger chain Byron from Gondola for £100m, following months of interest from private equity firms.
R Capital’s LDR Medical floats on Nasdaq
R Capital Management portfolio company LDR Medical raised $75m in an IPO on the Nasdaq, giving the company a market cap of $489m.
Gimv fully exits Ablynx
Gimv has sold its remaining direct stake of 2.24% in Euronext-listed Ablynx, a Belgian biotechnology company, for €19.1m.
Advent's Douglas close to Nocibé deal
German retailer Douglas Holding, a portfolio company of Advent International, is reportedly close to acquiring French perfume brand Nocibé from Charterhouse.
VC-backed Supercell secures $1.53bn from SoftBank
Finnish mobile games developer Supercell, backed by a consortium of venture capital firms, has raised $1.53bn from Japanese telecoms group SoftBank and GungHo Online Entertainment.
OEP's Constantia Flexibles to float
Packaging manufacturer Constantia Flexibles, owned by JP Morgan's private equity arm One Equity Partners (OEP), is planning its flotation, according to reports.
Mid Europa exits SBB/Telemach to KKR for €1bn
Mid Europa Partners has divested Serbian pay TV provider SBB/Telemach Group to KKR, reaping a 3x return on its original investment.
GED sells Grupo Sendal, reaps 2x return
GED has sold its stake in healthcare service provider Grupo Sendal to US-based Carefusion and reaped a 2x return.
FF&P Private Equity reaps 2.2x return on OB10 sale
FF&P Private Equity has sold OB10, a UK-based e-invoice network operator, to new holding company Tungsten Corporation, reaping a blended 2.2x its money.
Auven sells Spirogen in $240m trade sale
Auven Therapeutics has sold cancer drug pharmaceutical company Spirogen to US listed corporation AstraZeneca's subsidiary MedImmune for $240m.
Astorg and Abenex initiate Onduline sale
Astorg Partners and Abenex Capital are speaking with investment banks as they prepare to offload roofing materials company Onduline.